Amy M. Boddy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amy M. Boddy has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Carlo C. Maley
Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University
28 shared publications - Stefania E. Kapsetaki
Department of Biology, Tufts University, Medford, MA 02155, United States
24 shared publications - Tara M. Harrison
Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA
23 shared publications - Zachary T. Compton
Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University
23 shared publications - Lisa M. Abegglen
Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
22 shared publications - Elizabeth G. Duke
Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA
21 shared publications
Latest Publications
- 12 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 16 (1) , 7-9
Testing Nature’s Defenses: Inducing Cancer in the Naked Mole Rat
Summary: Although mice develop lung cancer from a single Eml4-Alk driver fusion, Shepard, Lester, and colleagues show that naked mole rats require three simultaneous oncogenic events: Eml4-Alk, Tp53 loss, and Rb1 loss, achieving only 30% tumor penetrance. This inducible cancer model in naked mole rats offers a unique platform for uncovering mechanisms of cancer resistance and modeling rare pleomorphic lung carcinomas. See related article by Shepard et al., p. 35
- 12 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 16 (1) , 7-9
Testing Nature’s Defenses: Inducing Cancer in the Naked Mole Rat
Summary: Although mice develop lung cancer from a single Eml4-Alk driver fusion, Shepard, Lester, and colleagues show that naked mole rats require three simultaneous oncogenic events: Eml4-Alk, Tp53 loss, and Rb1 loss, achieving only 30% tumor penetrance. This inducible cancer model in naked mole rats offers a unique platform for uncovering mechanisms of cancer resistance and modeling rare pleomorphic lung carcinomas. See related article by Shepard et al., p. 35
- Open Access
Immune-cancer analyses across mammals reveal a potential trophic level and platelet-linked tradeoff between cancer and trauma mortality
There may be fitness tradeoffs between wound healing, immune responses, and cancer development due to shared pathways, limited resources and conflicting selective pressures. The immune system is important in both response to injury and carcinogenesis. We initially investigated correlations between cancer prevalence and immune cells, controlling for known associations with body mass and lifespan. We analyzed data from 216 mammalian species from at least 20 individuals per species. Body mass correlated positively with segmented neutrophil-to-lymphocyte ratios and negatively with lymphocyte concentrations. However, only platelet concentration correlated (negatively) with cancer prevalence ( P -value = 0.006). To further understand this association, we investigated whether a fitness tradeoff could exist between preventing death from cancer versus injury. We discovered a negative correlation between cancer and trauma mortalities ( P -value ≤ 0.0006), even when we accounted for the fact that different causes of death must sum to 100%. Platelet size and trophic level negatively correlated with trauma mortality, but not when controlling for cancer mortality ( P -value = 0.06). If trauma mortality is an indirect measure of wound healing, this suggests a fitness tradeoff may exist between cancer suppression and wound healing across mammals, mediated in part through platelet size and trophic level.
Open AccessImmune-cancer analyses across mammals reveal a potential trophic level and platelet-linked tradeoff between cancer and trauma mortality
There may be fitness tradeoffs between wound healing, immune responses, and cancer development due to shared pathways, limited resources and conflicting selective pressures. The immune system is important in both response to injury and carcinogenesis. We initially investigated correlations between cancer prevalence and immune cells, controlling for known associations with body mass and lifespan. We analyzed data from 216 mammalian species from at least 20 individuals per species. Body mass correlated positively with segmented neutrophil-to-lymphocyte ratios and negatively with lymphocyte concentrations. However, only platelet concentration correlated (negatively) with cancer prevalence ( P -value = 0.006). To further understand this association, we investigated whether a fitness tradeoff could exist between preventing death from cancer versus injury. We discovered a negative correlation between cancer and trauma mortalities ( P -value ≤ 0.0006), even when we accounted for the fact that different causes of death must sum to 100%. Platelet size and trophic level negatively correlated with trauma mortality, but not when controlling for cancer mortality ( P -value = 0.06). If trauma mortality is an indirect measure of wound healing, this suggests a fitness tradeoff may exist between cancer suppression and wound healing across mammals, mediated in part through platelet size and trophic level.
- Open Access
- 24 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10333
Immunological surveillance against cancer across mammals
Contrary to expectations based on their higher cell numbers, larger and longer-lived species do not face dramatically increased risk of cancer. This strongly suggests that evolution has fashioned natural cancer resistance mechanisms, yet our knowledge remains limited on what these mechanisms might be. The cancer immunological surveillance hypothesis, proposed by Burnet and Thomas in the 1950s, highlights immunity as a key factor determining species-specific cancer resistance. Here we address the original, evolutionary interpretation of this hypothesis by investigating the relationship between cancer mortality risk and markers of efficient antigen presentation. Our results show that the expansion of the MHC class I gene complex, as well as increased selection for diversity at these genes is associated with sharply decreasing cancer mortality risk across mammals. This suggests that the efficient presentation of diverse peptides in somatic cells is important for cancer suppression across mammals, providing pioneering evidence that supports the cancer immunosurveillance hypothesis across species.
- 24 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10333
Open AccessImmunological surveillance against cancer across mammals
Contrary to expectations based on their higher cell numbers, larger and longer-lived species do not face dramatically increased risk of cancer. This strongly suggests that evolution has fashioned natural cancer resistance mechanisms, yet our knowledge remains limited on what these mechanisms might be. The cancer immunological surveillance hypothesis, proposed by Burnet and Thomas in the 1950s, highlights immunity as a key factor determining species-specific cancer resistance. Here we address the original, evolutionary interpretation of this hypothesis by investigating the relationship between cancer mortality risk and markers of efficient antigen presentation. Our results show that the expansion of the MHC class I gene complex, as well as increased selection for diversity at these genes is associated with sharply decreasing cancer mortality risk across mammals. This suggests that the efficient presentation of diverse peptides in somatic cells is important for cancer suppression across mammals, providing pioneering evidence that supports the cancer immunosurveillance hypothesis across species.
- Open Access
- 24 October 2025
- Published by Wiley in Advanced Science
- Vol. 12 (48) , e14969
Identifying Key Questions and Challenges in Microchimerism Biology
Microchimerism research has recently gained renewed attention despite known existence of these rare cells for decades. Fetal and maternal microchimeric‐derived cells may have functional capabilities, and are increasingly associated with both beneficial and adverse health outcomes. Yet, establishing the role of microchimerism in health has been largely constrained methodologically and theoretically. The Microchimerism, Human Health, and Evolution Project address these challenges by calling on 29 leading microchimerism experts to put forth key research questions that can substantially advance the field. Seven major categories are identified: function and mechanism; microchimerism in interventions, treatment, and transplant; mapping “generational microchimerism”; evolution; microchimerism detection; appropriate experimental model systems; and definition of microchimerism. Identifying these questions ‐ and continuing to find answers ‐ will be crucial for advancing the knowledge of microchimerism in health and disease.
- 24 October 2025
- Published by Wiley in Advanced Science
- Vol. 12 (48) , e14969
Open AccessIdentifying Key Questions and Challenges in Microchimerism Biology
Microchimerism research has recently gained renewed attention despite known existence of these rare cells for decades. Fetal and maternal microchimeric‐derived cells may have functional capabilities, and are increasingly associated with both beneficial and adverse health outcomes. Yet, establishing the role of microchimerism in health has been largely constrained methodologically and theoretically. The Microchimerism, Human Health, and Evolution Project address these challenges by calling on 29 leading microchimerism experts to put forth key research questions that can substantially advance the field. Seven major categories are identified: function and mechanism; microchimerism in interventions, treatment, and transplant; mapping “generational microchimerism”; evolution; microchimerism detection; appropriate experimental model systems; and definition of microchimerism. Identifying these questions ‐ and continuing to find answers ‐ will be crucial for advancing the knowledge of microchimerism in health and disease.
- Open Access
- 12 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
The relationship between diet, plasma glucose, and cancer prevalence across vertebrates
Birds have higher plasma glucose concentrations but lower cancer prevalence than other vertebrates. However, this inverse relationship between glucose and cancer may not hold within vertebrate groups. Given that diet affects blood sugar levels, and carnivores have higher cancer risk than herbivores, we also examined whether diet correlates with plasma glucose concentrations. We collected diet, mean plasma glucose concentration, and neoplasia data for up to 273 vertebrate species from existing databases. Across vertebrates, mean plasma glucose concentration negatively correlated with cancer prevalence, but that was mostly driven by differences in mean plasma glucose concentration and cancer prevalence between birds, mammals, and reptiles. Mean plasma glucose concentration was not correlated with diet across vertebrates nor with cancer prevalence within birds, mammals, or reptiles. Primary carnivores had higher neoplasia prevalence than herbivores when controlling for domestication. A hypothetical explanation for our results may be the evolutionary loss or downregulation of genes related to insulin-mediated glucose import in bird cells. This may have led to higher mean plasma glucose concentration, lower intracellular glucose concentrations in the form of glycogen, and production of fewer reactive oxygen species and inflammatory cytokines, potentially contributing to lower neoplasia prevalence in extant birds compared to mammals and reptiles.
- 12 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Open AccessThe relationship between diet, plasma glucose, and cancer prevalence across vertebrates
Birds have higher plasma glucose concentrations but lower cancer prevalence than other vertebrates. However, this inverse relationship between glucose and cancer may not hold within vertebrate groups. Given that diet affects blood sugar levels, and carnivores have higher cancer risk than herbivores, we also examined whether diet correlates with plasma glucose concentrations. We collected diet, mean plasma glucose concentration, and neoplasia data for up to 273 vertebrate species from existing databases. Across vertebrates, mean plasma glucose concentration negatively correlated with cancer prevalence, but that was mostly driven by differences in mean plasma glucose concentration and cancer prevalence between birds, mammals, and reptiles. Mean plasma glucose concentration was not correlated with diet across vertebrates nor with cancer prevalence within birds, mammals, or reptiles. Primary carnivores had higher neoplasia prevalence than herbivores when controlling for domestication. A hypothetical explanation for our results may be the evolutionary loss or downregulation of genes related to insulin-mediated glucose import in bird cells. This may have led to higher mean plasma glucose concentration, lower intracellular glucose concentrations in the form of glycogen, and production of fewer reactive oxygen species and inflammatory cytokines, potentially contributing to lower neoplasia prevalence in extant birds compared to mammals and reptiles.
- Open Access
- 13 February 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 1-19
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective
The transfer of a small number of cells between parent and offspring during pregnancy, commonly referred to as microchimerism, is thought to occur in all human pregnancies. The impact of microchimeric cells on health outcomes in mothers and offspring with respect to cancer, remains unknown. Molecular and epidemiological studies yield conflicting results on the link between microchimerism and cancer, underscoring the complexity of this phenomenon. Further, most studies on microchimerism and cancer focus on the relationship between circulating fetal cells in parous women. Given that the cellular exchange between the mother and offspring is thought to have arisen due to the evolution of internal gestation, we provide an evolutionary perspective on how internal gestation may impact the risk of cancer in humans. We highlight the potential mechanisms that may play a role in cancer vulnerability in mammals, such as genomic conflict and placental invasion. We then review the literature to investigate the effects of microchimerism on cancer outcomes in parous women, highlighting each study's interpretation of the role microchimeric cells play in cancer development, whether it is a protective or contributing role. We conclude that our current understanding of the relationship between microchimerism and cancer is poorly understood and propose mechanisms for when we would expect to see microchimerism contribute to a role in protecting the host from cancer and when microchimerism may contribute to tumor development. Future studies, including more advanced methods to detect and identify microchimerism, will be important for elucidating the link between microchimerism and cancer initiation and progression.
- 13 February 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 1-19
Open AccessThe duality of microchimerism and cancer in parous women: a review and evolutionary perspective
The transfer of a small number of cells between parent and offspring during pregnancy, commonly referred to as microchimerism, is thought to occur in all human pregnancies. The impact of microchimeric cells on health outcomes in mothers and offspring with respect to cancer, remains unknown. Molecular and epidemiological studies yield conflicting results on the link between microchimerism and cancer, underscoring the complexity of this phenomenon. Further, most studies on microchimerism and cancer focus on the relationship between circulating fetal cells in parous women. Given that the cellular exchange between the mother and offspring is thought to have arisen due to the evolution of internal gestation, we provide an evolutionary perspective on how internal gestation may impact the risk of cancer in humans. We highlight the potential mechanisms that may play a role in cancer vulnerability in mammals, such as genomic conflict and placental invasion. We then review the literature to investigate the effects of microchimerism on cancer outcomes in parous women, highlighting each study's interpretation of the role microchimeric cells play in cancer development, whether it is a protective or contributing role. We conclude that our current understanding of the relationship between microchimerism and cancer is poorly understood and propose mechanisms for when we would expect to see microchimerism contribute to a role in protecting the host from cancer and when microchimerism may contribute to tumor development. Future studies, including more advanced methods to detect and identify microchimerism, will be important for elucidating the link between microchimerism and cancer initiation and progression.
- Open Access
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S71 from Cancer Prevalence across Vertebrates
Analysis our of our regression results with various data transformation techniques
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S71 from Cancer Prevalence across Vertebrates
Analysis our of our regression results with various data transformation techniques
- Open Access
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Cancer Prevalence across Vertebrates
Results from the bootstrap analysis of different sample size cutoffs
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Cancer Prevalence across Vertebrates
Results from the bootstrap analysis of different sample size cutoffs
- Open Access
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Cancer Prevalence across Vertebrates
All data prevalence leaderboard
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Cancer Prevalence across Vertebrates
All data prevalence leaderboard
- Open Access
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S70 from Cancer Prevalence across Vertebrates
Analysis of our results with the outlier species removed
- 13 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S70 from Cancer Prevalence across Vertebrates
Analysis of our results with the outlier species removed